Azienda Ospedaliero-Universitaria Careggi

Florence, Firenze 50134

1 studies enrolling now · 2 studies all time

What they study most

Angina Pectoris, Coronary Artery Disease, Neurotrophic Keratopathy

Studies at this site

• Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 — Recruiting now
• Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) — Completed